MRI Improves Diagnosis of Fetal Brain Abnormalities
New research published in The Lancet suggests that adding MRI after the mid-pregnancy scan could provide more certainty in diagnosing fetal brain abnormalities. The study involved 570 women whose mid-pregnancy ultrasound scan revealed a potential brain abnormality in the fetus. Within two weeks of their first scan they were given an extra scan using MRI, which increased accuracy of the diagnosis meaning almost all scans (93 percent) were correct.
See Also: Mapping the Fetal Brain: New Technique
"This study is the first of its kind and has shown that adding an MRI scan when a problem is detected provides additional information to support parents making decisions about their pregnancy," says lead author Professor Paul Griffiths from The University of Sheffield, UK. "Based on our findings we propose that an MRI scan should be given in any pregnancy where the fetus may have a suspected brain abnormality."
The MRI gave extra information about the brain abnormality in nearly half of cases (49 percent). For example, in one case the MRI confirmed the ultrasound diagnosis and identified an additional abnormality. This information allowed doctors to give parents a more certain outlook, halving (55 percent) the number of cases in the "unknown" prognosis group and increasing the number of pregnancies predicted to be "normal" (135 percent), "favourable" (18 percent) or "poor" (56 percent).
In the study, doctors analysing the ultrasound and MRI scans were asked to rate how confident they were of their diagnosis. The study also analysed how the MRI result changed the prognosis and advice given by physicians.
Doctors using MRI were more confident of their diagnosis – saying they had "high confidence" in 95 percent of cases (544 of 570), compared with 82 percent (465 of 570 cases) for doctors using ultrasound. In addition, doctors agreed that the extra MRI scan changed the outlook for the pregnancy in at least 20 percent of cases (157 of 783). And as a result this changed how the pregnancy was managed in one in three cases (34 percent).
Interestingly, 95 percent (257 of 270) of mothers said that they would have an MRI scan if a future pregnancy showed a brain abnormality and around 80 percent (227 of 277) said that the information from the scan helped them better understand their baby's condition.
The researchers will perform further analysis of the trial's results, including a health economics analysis, to confirm if the extra scan should be used routinely. Only cases identified by the ultrasound scan were given the extra MRI, so any cases where an ultrasound did not identify an abnormality would not have been included in this study.
"Accurate diagnosis of significant brain abnormalities has important therapeutic implications. Consequently, it is essential that tools used for prenatal diagnosis are rigorously evaluated," Professor Rod Scott, University of Vermont, USA, writes in a linked commentary. "This trial strongly supports the view that iuMRI is an excellent technique, and it should be incorporated into clinical practice as soon as possible."
Source: The Lancet
Image Credit: Wikimedia Commons
Published on : Mon, 19 Dec 2016
The iViz is a lightweight Point Of Care (POC) ultrasound solution, specifically designed for emerging sub-segments where there is need for a highly accessible and mobile solution that is capable throughout key areas of the patient care path. The iViz...
The SonoSite EDGE II is a high-resolution, all-digital, 9.0-pound (4.1 kg) ultrasound system with a 12.1in. LED full-bleed glass display. The Edge II boosts improvements in cardiac and abdominal image quality through DirectClear Technology and a new...
A breakthrough in biopsy efficiency The Brevera system streamlines the entire breast biopsy process from start to finish – with real-time imaging for instant verification and automated post-biopsy specimen handling. This has the potential to...
A better 3D™ breast screening experience – for everyone. The new 3Dimensions™ system is designed to provide higher quality 3D™ images for radiologists, a more comfortable mammography experience for patients and enhanced workflow for technologists....
BioZorb® 3D Bioabsorbable Marker The BioZorb® is a 3D implantable marker that consists of a spiral, bioabsorbable framework embedded with 6 permanent, titanium clips designed to precisely mark your surgical excision site. Designed to improve outcomes...